Literature DB >> 36223038

Comment on: "A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS)".

Yoshihiro Noguchi1.   

Abstract

Entities:  

Year:  2022        PMID： 36223038     DOI： 10.1007/s40264-022-01240-w

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.228


× No keyword cloud information.
  7 in total

1.  Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole.

Authors:  E P Van Puijenbroek; A C Egberts; R H Meyboom; H G Leufkens
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 2.  The reporting odds ratio and its advantages over the proportional reporting ratio.

Authors:  Kenneth J Rothman; Stephan Lanes; Susan T Sacks
Journal:  Pharmacoepidemiol Drug Saf       Date:  2004-08       Impact factor: 2.890

3.  A statistical methodology for drug-drug interaction surveillance.

Authors:  G Niklas Norén; Rolf Sundberg; Andrew Bate; I Ralph Edwards
Journal:  Stat Med       Date:  2008-07-20       Impact factor: 2.373

4.  Comparison of Signal Detection Algorithms Based on Frequency Statistical Model for Drug-Drug Interaction Using Spontaneous Reporting Systems.

Authors:  Yoshihiro Noguchi; Tomoya Tachi; Hitomi Teramachi
Journal:  Pharm Res       Date:  2020-04-30       Impact factor: 4.200

5.  A Disproportionality Analysis of Drug-Drug Interactions of Tizanidine and CYP1A2 Inhibitors from the FDA Adverse Event Reporting System (FAERS).

Authors:  Lorenzo Villa-Zapata; Ainhoa Gómez-Lumbreras; John Horn; Malinda S Tan; Richard D Boyce; Daniel C Malone
Journal:  Drug Saf       Date:  2022-07-14       Impact factor: 5.228

Review 6.  Review of Statistical Methodologies for Detecting Drug-Drug Interactions Using Spontaneous Reporting Systems.

Authors:  Yoshihiro Noguchi; Tomoya Tachi; Hitomi Teramachi
Journal:  Front Pharmacol       Date:  2019-11-08       Impact factor: 5.810
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.